Publication | Open Access
RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells
35
Citations
41
References
2018
Year
RIPL-NLCs are good candidates for Hpn-selective drug targeting with a high loading capacity of hydrophobic drug molecules.
| Year | Citations | |
|---|---|---|
1986 | 6.8K | |
1989 | 1.8K | |
2002 | 1.2K | |
2009 | 931 | |
2007 | 676 | |
2010 | 524 | |
2013 | 365 | |
2007 | 318 | |
2017 | 305 | |
2006 | 274 |
Page 1
Page 1